BEIJING, June 11, 2021 /PRNewswire/ -- Concord Medical
Services Holdings Limited ("Concord Medical" or the "Company")
(NYSE: CCM), a healthcare provider specializing in cancer care,
research and prevention by operating a network of medically
advanced comprehensive cancer hospitals and standalone radiotherapy
and diagnostic imaging centers in China, today announced that its Guangzhou
Concord Cancer Center ("GCCC"), which is certified as a tertiary
specialty hospital by the National Health Commission, is now in
operation. This has marked a major milestone for the Company.
Situated in Sino-Singapore
Guangzhou Knowledge City, Guangzhou's newest modern development
district, GCCC is a specialty cancer hospital and is built in
strict compliance with domestic tertiary hospital standards, the
highest domestic standards for medical institutions. As a support
institution of the Society of Tumor Microenvironment, China
Anti-Cancer Association and a member of the Union for International
Cancer Control, GCCC is equipped with the state-of-the-art medical
technologies, including the Probeam proton system, whose
superconducting cyclotron is one of the most powerful particle
accelerators available today to treat cancer with exceptional
precision. Utilizing the cutting-edge medical technologies, GCCC
aims to and is committed to providing patients with
multi-disciplinary healthcare services and patient-centered
experience in strict compliance with international standards for
cancer diagnosis and treatment. Concord Medical aims to build an
internationalized cancer center specializing in clinical diagnosis
and treatment, cancer prevention, medical research, specialist
training and remote medical consultation in Guangzhou to benefit all cancer patients.
GCCC is operated by Meizhong Jiahe Medical Science &
Technology Development Group Co., Ltd. ("Meizhong Jiahe"), a
subsidiary of Concord Medical, and is established in cooperation
with top international and domestic medical institutions.
Constructed since 2010, GCCC is now able to provide patients with
full-process medical services from cancer prevention to
recovery.
About Concord Medical
Concord Medical Services Holdings Limited is a healthcare
provider specialized in cancer treatment, research, education and
prevention. The Company operates a network of medically advanced
comprehensive cancer hospitals and standalone radiotherapy and
diagnostic imaging centres in China. The Company focuses on providing
multidisciplinary cancer care approach in all areas of oncology
services in its cancer hospitals. The Company also equips its
hospitals with technologically advanced equipment such as the
state-of-the-art proton therapy system in its premium cancer
hospitals in top-tier cities including Beijing, Shanghai, and Guangzhou. In addition, the Company saw the
opportunity of the expanding market of medical equipment in
China and developed its product
life-cycle management services form its existing medical equipment
and consumable sales services. As of December 31, 2020, the
Company operated a network of 27 radiotherapy centers and
diagnostic imaging centers, which are based in 20 hospitals,
established under long-term lease and management services
arrangements with the Company and spanning over 20 cities across 13
provinces and administrative regions in China. To ensure the
commitment to the highest standard of medical services for
patients, the Company offers ongoing education and training for
doctors and other medical professionals in its network hospitals
and centres in both domestic and overseas medical institutions.
For more information, please see
http://ir.ccm.cn.
Safe Harbor Statement
This announcement contains forward-looking statements. These
forward-looking statements can be identified by words or phrases
such as "will," "expects," "anticipates," "future," "intends,"
"plans," "believes," "estimates" and similar expressions.
Forward-looking statements are inherently subject to uncertainties
and contingencies beyond the Company's control and based upon
premises with respect to future business decisions, which are
subject to change. A number of important factors could cause actual
results to differ materially from those contained in any
forward-looking statement. The Company does not undertake any
obligation to update any forward-looking statement, except as
required under applicable law.
View original
content:http://www.prnewswire.com/news-releases/concord-medical-officially-opens-new-specialty-cancer-hospital-in-guangzhou-301310795.html
SOURCE Concord Medical Services Holdings Limited